Evidence map›Paper›PMID 33690991›Full record

Observational studyCancer cytopathology2021

Cytopathology of bronchoalveolar lavages in COVID___19 pneumonia: A pilot study.

Valentina Canini, Francesca Bono, Paolo Calzavacca, Giulia Capitoli, Giuseppe Foti, Filippo Fraggetta, Stefania Galimberti, Andrea Gianatti, Marco Giani, Ahmed Nasr and 4 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Cancer cytopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Valentina CaniniPathology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Francesca BonoPathology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Paolo CalzavaccaEmergency and Intensive Care, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Giulia CapitoliBicocca Bioinformatics Biostatistics and Bioimaging B4 Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Giuseppe FotiEmergency and Intensive Care, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Filippo FraggettaPathology, Cannizzaro Hospital, Catania, Italy.
Stefania GalimbertiBicocca Bioinformatics Biostatistics and Bioimaging B4 Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Andrea GianattiAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Marco GianiEmergency and Intensive Care, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Ahmed NasrPathology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Giuseppe PacioccoPneumology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Fabio PagniPathology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0001-9625-1637
Roberto RonaEmergency and Intensive Care, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Vincenzo L'ImperioPathology, Department of Medicine and Surgery, Azienda Socio Sanitaria Territoriale di Monza, University of Milano-Bicocca, Monza, Italy.
Azienda Socio Sanitaria Territoriale Lariana · ITUniversity of Milano-Bicocca · ITOspedale Cannizzaro · ITOspedale Papa Giovanni XXIII · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBronchoalveolar lavage (BAL) in patients with severe coronavirus disease 2019 (COVID-19) may provide additional and complementary findings for the management of these patients admitted to intensive care units (ICUs). This study addresses the cytological features of the infection and highlights the more influential inflammatory components. The correlation between pathological variables and clinical data is also analyzed.

methodsThe authors performed a retrospective analysis of the cytopathological features of BAL in 20 COVID-19 patients and 20 members of a matched cohort from a critical ICU who had acute respiratory distress syndrome caused by other pulmonary conditions.

resultsA comparison of the controls (n = 20) and the COVID-19 patients (n = 20) revealed that the latter had a higher neutrophil count (median, 63.8% of the cell count) with lower percentages of macrophages and lymphocytes. An increase in the expression of CD68-positive, monocytic multinucleated giant cells (MGCs) was reported; megakaryocytes were not detected on CD61 staining. Perls staining showed isolated elements. In situ RNA analysis demonstrated scattered chromogenic signals in type II pneumocytes. An ultrastructural analysis confirmed the presence of intracytoplasmic vacuoles containing rounded structures measuring 140 nm in diameter (putative viral particles). In COVID-19 patients, the clinicopathological correlation revealed a positive correlation between lactate dehydrogenase values and MGCs (r = 0.54).

conclusionsThe analysis of BAL samples might be implemented as a routine practice for the evaluation of COVID-19 patients in ICUs in the appropriate clinical scenario. Additional studies using a larger sample size of patients who developed COVID-19 during the second wave of the epidemic in the autumn of 2020 are needed to further support our findings.

Indexed as

AdultAgedBronchoalveolar Lavage FluidCOVID-19FemaleHumansMaleMiddle AgedPilot ProjectsPneumonia, ViralRetrospective StudiesSARS-CoV-2bronchoalveolar lavage (BAL)coronavirus disease 2019 (COVID-19)multinucleated giant cellsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID33690991
PMCPMC8239788
OpenAlexW3134082290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.